All Articles

6 ARTICLES TAGGED "DRUG DISCOVERY"

The AI-Native Shift: Solving the Data Bottleneck in Legal & Pharma in 2024

The AI-native transformation marks a critical shift from simple data generation to the rigorous validation of insights. Explore how this evolution is reshaping legal practice, drug discovery, and the funding landscape for 10x Science.

9 min readRead →

Claude Aiclaude ainewsJul 24, 2026

Claude Drug Discovery: Anthropic's Superintelligence Targets Rare Diseases in 2026

Anthropic is leveraging Claude’s superintelligence to tackle the complex challenges of rare disease drug discovery. By 2026, this AI-driven approach aims to reduce costs and accelerate life-saving treatments for patients worldwide.

5 min readRead →

AI NewschatgptnewsJul 11, 2026

GPT-5.4 and the Rise of Autonomous AI Chemists: A New Era for Drug Discovery in 2026

GPT-5.4 is transforming drug discovery from a decade-long marathon into a rapid sprint. By integrating OpenAI’s latest model with advanced chemistry labs, autonomous AI chemists are now capable of developing life-saving medicines in just weeks.

4 min readRead →

AI ToolsgeneralnewsJun 4, 2026

GPT-Rosalind Biology AI: Revolutionizing Life Sciences and Chemistry in 2026

Explore GPT-Rosalind, OpenAI's specialized AI poised to transform life sciences and chemistry. This AI is set to accelerate breakthroughs in drug discovery and genomics.

11 min readRead →

AI Newsai newsnewsApr 17, 2026

GPT-Rosalind vs GPT-5.4-Cyber: OpenAI's Specialized Frontier AI Models of 2026

OpenAI has introduced GPT-Rosalind for specialized research in drug discovery and genomics, alongside GPT-5.4-Cyber, a model dedicated to strengthening global cybersecurity infrastructure through API grants and trusted access.

8 min readRead →

Claude Aiclaude aiguideApr 6, 2026

Anthropic Expands into Biotech with $400M Acquisition of Coefficient Bio

Anthropic has acquired stealth biotech startup Coefficient Bio, integrating a team of former Genentech researchers to accelerate AI applications in healthcare and life sciences. This move signals a major pivot toward specialized vertical AI in the medical field.

13 min readRead →